scholarly journals A Severe Neuroleptic Malignant Syndrome Treated with Daily Electroconvulsive Therapy: A Case Report

2021 ◽  
Author(s):  
S. Ozlem Erden Aki ◽  
Ahmet Gurcan ◽  
S. Can Gurel ◽  
M. Kazim Yazici
Keyword(s):  
Case Report ◽  
Neuroleptic Malignant Syndrome ◽  
Electroconvulsive Therapy

Olanzapine induced neuroleptic malignant syndrome, treated with electroconvulsive therapy (ECT)—A case report

2017 ◽  
Vol 30 ◽  
pp. 230-231 ◽  
Author(s):  
Mustafa Ali ◽  
Soumitra Das ◽  
Jagadisha Thirthalli ◽  
Nagavarapu Leela Shankar Sastry
Keyword(s):  
Case Report ◽  
Neuroleptic Malignant Syndrome ◽  
Electroconvulsive Therapy

scholarly journals Catatonia, Neuroleptic Malignant Syndrome, and Cotard Syndrome in a 22-Year-Old Woman: A Case Report

2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
C. Weiss ◽  
J. Santander ◽  
R. Torres
Keyword(s):  
Case Report ◽  
Neuroleptic Malignant Syndrome ◽  
Electroconvulsive Therapy ◽  
Life Support ◽  
Point Of View ◽  
Neurological Damage ◽  
Catatonic Syndrome

The following case study describes a 22-year-old woman with depression and symptoms of psychosis who developed neuroleptic malignant syndrome after using Risperidone, thus requiring life support equipment and Bromocriptine, later recovering after seven days. From a psychiatric and neurological point of view, however, the persistence of catatonic syndrome and Cotard syndrome delusions was observed, based on assertions such as “I do not have a heart,” “my heart is not beating,” “I can not breathe,” “I am breaking apart,” “I have no head” (ideas of negation) and statements about the patient being responsible for the “death of the whole world” (ideas of enormity). Brain NMR revealed leukoencephalopathy, interpreted as scar lesions caused by perinatal neurological damage, after discarding other pathologies. The patient responded well to electroconvulsive therapy after 11 sessions. Organic vulnerability to these syndromes, as well as their coexistence and clinical differentiation is discussed in the light of the data observed.

scholarly journals Electroconvulsive Therapy for Parkinson's Disease with Depression and Neuroleptic Malignant Syndrome: A Case Report

2021 ◽  
Vol 19 (3) ◽  
pp. 572-575
Author(s):  
Yuhei Mori ◽  
Itaru Miura ◽  
Michinari Nozaki ◽  
Yusuke Osakabe ◽  
Ryuta Izumi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Case Report ◽  
Neuroleptic Malignant Syndrome ◽  
Electroconvulsive Therapy

scholarly journals Propofol-Remifentanil Combination for Management of Electroconvulsive Therapy in a Patient with Neuroleptic Malignant Syndrome

2012 ◽  
Vol 2012 ◽  
pp. 1-3
Author(s):  
Modabber Arasteh ◽  
Shoaleh Shami ◽  
Karim Nasseri
Keyword(s):  
Case Report ◽  
Neuroleptic Malignant Syndrome ◽  
Male Patient ◽  
Electroconvulsive Therapy ◽  
Muscle Relaxant ◽  
Treatment Resistant ◽  
Successful Management ◽  
Therapy Sessions

Electroconvulsive therapy can be effective in severe or treatment resistant neuroleptic malignant syndrome patients. Anesthesia and use of muscle relaxant agents for electroconvulsive therapy in such patients may encounter anesthesiologists with specific challenges. This case report describes successful management of anesthesia in 28-year-old male patient undergoing eight electroconvulsive therapy sessions for treatment of neuroleptic malignant syndrome.

scholarly journals Bitemporal ultra-brief pulse electroconvulsive therapy for the treatment of neuroleptic malignant syndrome in a first psychotic episode: a case report

2017 ◽  
Vol 39 (1) ◽  
pp. 62-63 ◽  
Author(s):  
Kathy Aleixo Marcolin ◽  
Cazuza Oliveira Rodrigues ◽  
Tissiana Maria Falcão Muller ◽  
Felipe Salles de Salles ◽  
Vitor Calegaro ◽  
...  
Keyword(s):  
Case Report ◽  
Neuroleptic Malignant Syndrome ◽  
Electroconvulsive Therapy ◽  
Psychotic Episode ◽  
First Psychotic Episode

A Case of Catatonia in a 14-Year-Old Girl with Schizophrenia Treated with Electroconvulsive Therapy

2013 ◽  
Vol 41 (1) ◽  
pp. 69-74 ◽  
Author(s):  
Frank Häßler ◽  
Olaf Reis ◽  
Steffen Weirich ◽  
Jacqueline Höppner ◽  
Birgit Pohl ◽  
...  
Keyword(s):  
Case Report ◽  
Treatment Response ◽  
Electroconvulsive Therapy ◽  
Rating Scale ◽  
Combined Treatment ◽  
Adolescent Patient

This article presents a case of a 14-year-old female twin with schizophrenia who developed severe catatonia following treatment with olanzapine. Under a combined treatment with amantadine, electroconvulsive therapy (ECT), and (currently) ziprasidone alone she improved markedly. Severity and course of catatonia including treatment response were evaluated with the Bush-Francis Catatonia Rating Scale (BFCRS). This case report emphasizes the benefit of ECT in the treatment of catatonic symptoms in an adolescent patient with schizophrenic illness.

Sign in / Sign up

Export Citation Format

Share Document